| Primary information |
|---|
| CancerPDF_ID | CancerPDF_ID10339 |
| PMID | 21805675 |
| Peptide Sequence | LVRYTKKVPQVSTPTL |
| Peptide Sequence in Publication | L.LVRYTKKVPQVSTPTL.V |
| Protein Name | Serum albumin precursor |
| UniprotKB Entry Name | ALBU_HUMAN |
| Biofluid | Urine |
| M/Z | 1830.0049 |
| Charge | NA |
| Mass/H+ | NA |
| Mass (in Daltons) | NA |
| Profiling Technique | MALDI-TOF |
| Peptide Identification Technique | MALDI-TOF-MS |
| Quantification Technique | NA |
| Labeling | Label Free |
| FDR | 1 |
| p-Value | 6.60E-16 |
| Software | NA |
| Length of Peptide | 16 |
| Cancer Type | Muscle-invasive bladder cancer |
| Database for Peptide search | SwissProt Database |
| Modification | NA |
| Number of Patients | 751 bladder cancer and 127 control |
| Regulation/Differential Expression | Upregulated in cancer vs normal |
| Validation | Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | 0.703 |
| Secondary information |
|---|
| Peptide Atlas | NA |
| IEDB | 439054
|